I contacted Dr. Alain Fischer once, read message here. And his response here. FDA Halts Gene Therapy Experiments; By Rick Weiss, Washington Post Staff Writer, Thursday, March 3, 2005; 2:20 PM The Food and Drug Administration has suspended several U.S. gene therapy experiments after learning that a third child
NEMO Gene Archive
Safer route to gene therapy found Scientists say they have found a safer way of controlling genes to treat disease. Current methods of switching genes on and off usually involve complicated systems and have serious side effects like cancer. Scientists at the Children’s Hospital in Boston say their new
The Journal of Clinical Investigation found today 2 articles citing Dr. Orange research on NEMO. Dr. Orange’s article is “Deficient natural killer cell cytotoxicity in patients with IKK-{gamma}/NEMO mutations” published in 2002. And the articles are: Combined deficiency in I{kappa}B{alpha} and I{kappa}B{epsilon} reveals a critical window of NF-{kappa}B activity
On the Journal of Clinical Allergy and Immunology: The presentation and natural history of immunodeficiency caused by nuclear factor kappaB essential modulator mutation. Orange JS, Jain A, Ballas ZK, Schneider LC, Geha RS, Bonilla FA. Department of Immunology, Children’s Hospital, 300 Longwood Avenue, Boston, MA 02115, USA. BACKGROUND: An
Finding NEMO: genetic disorders of NFkB activation Jordan S. Orange and Raif S. Geha Division of Immunology, Children’s Hospital and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA Comentary about NEMO from Dr. Jordan Orange, Dr. Raif S. Geha. Read the Commentary here. ATF
Deficient natural killer cell cytotoxicity in patients with IKK-γ/NEMO mutations Jordan S. Orange, Scott R. Brodeur, Ashish Jain, Francisco A. Bonilla, Lynda C. Schneider, Roberto Kretschmer, Samuel Nurko, Wendy L. Rasmussen, Julia R. Köhler, Stephen E. Gellis, Betsy M. Ferguson, Jack L. Strominger, Jonathan Zonana, Narayanaswamy Ramesh, Zuhair K.